6 Recruiting Oropharyngeal Squamous Cell Carcinoma Phase 2 Clinical Trials

Active phase 2 studies for oropharyngeal squamous cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Oropharyngeal Squamous Cell Carcinoma studies

Phase 2 Studies for Oropharyngeal Squamous Cell Carcinoma

🔵 Active, Not Recruiting Phase2

Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

📍 Cliniques Universitaires Saint-Luc — Brussels,

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase1 / Phase2

Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma

📍 NYU Langone Health — New York, New York

View Study & Checklist ➔

🟢 Recruiting Phase2

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

📍 University of Cincinnati Medical Center — Cincinnati, Ohio

View Study & Checklist ➔

🟢 Recruiting Phase2

Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma

📍 University of Florida — Gainesville, Florida

View Study & Checklist ➔

🟢 Recruiting Phase2

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

📍 Washington University School of Medicine — St Louis, Missouri

View Study & Checklist ➔

🟢 Recruiting Phase2

Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

📍 Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah

View Study & Checklist ➔